ReviewDNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis
Introduction
A widely held view is that the initial reaction of a cell to DNA damage is to repair the damage. However, with increasing levels of DNA damage the cell switches to cell cycle arrest or to apoptosis. Cell cycle arrest is sometimes permanent, but ordinarily reversible, allowing time for further DNA repair. The maintenance of a switching mechanism that shifts the cell from DNA repair to apoptosis, as appropriate in the presence of excessive DNA damage, appears to be of central importance for avoiding progression to cancer. The default mechanism of apoptosis prevents clonal expansion of cells in which unrepaired damage would lead to mutation and to carcinogenesis (Fig. 1).
During progression to cancer, the capability of cells to undergo apoptosis is often reduced, suggesting that the normal ability to undergo apoptosis is protective against cancer. For example, loss of the capacity to undergo apoptosis occurs early in the progression to adenocarcinoma of the colon [1], [2], [3] and esophagus [4], [5]. Apoptosis capability may be reduced in three ways: by mutation, by silencing or loss of genes encoding required components of the apoptosis pathway (e.g. p53 and bax) [6], [7], or by persistent activation of genes encoding apoptosis suppressors (e.g. bcl-2) [8]. Failure to undergo apoptosis in the face of unrepaired damage leads to enhanced mutation [9], [10], [11], including chromosome aberrations, and can be a cause of the genomic instability that is a general characteristic of cancer progression [12].
In the following sections, we discuss the various specific DNA repair processes, how these processes recognize and repair DNA damage, and how they switch from repair to apoptosis when DNA damage presumably overwhelms repair capacity. One should keep in mind, however, that of necessity most of the mechanistic information provided is based on in vitro or purified enzyme studies and, thus, may or may not reflect processes in vivo in man. Similarly, biochemical events observed in cultured cells or with purified enzymes may provide valuable clues to in vivo processes, but may not be exactly correct.
There are two distinct types of cell death in vivo, apoptosis and necrosis [13], [14], [15]. Apoptosis is a controlled form of cell death, in which the cell undergoes “cellular suicide”. The cell shrinks, dehydrates, fragments its nucleus, and is phagocytized by macrophages [16]. Necrosis, on the other hand, is a traumatic, but passive, form of cell death, in which ion pumps fail, the cell swells and then undergoes lysis with the release of inflammatory mediators [13], [17].
A cell will first try to repair any DNA damage and survive; however, if DNA damages are excessive, the preferred mode of cell death in a multicellular organism is apoptosis, a process which does not elicit an inflammatory response. How does a cell ensure that its death will occur by apoptosis, rather than necrosis? Given that both DNA repair and apoptosis are energy-demanding processes, the answer may lie in the proper utilization of the available ATP in the cell (Fig. 2) [18], [19], [20]. Energy is required for both DNA repair [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35] and apoptosis [18], [36], [37], [38], [39], [40]. In addition, during both DNA repair and apoptosis, the ATP-dependent ion pumps that keep Ca++ [41] at a low cytosolic concentration and sustain a critical internal K+ concentration [42] need to be maintained.
If the repair of DNA damage is prolonged in any given cell, an “energy catastrophe” [43] will occur (Fig. 2). The considerable investment of energy to repair DNA was particularly noted by Roca and Cox [25] in bacteria, where they pointed out the “profligate” chemical energy invested in the degradation and replacement of a strand of DNA, 1000 bases or more in length, to repair one DNA mismatch. Therefore, in mammalian cells, a large amount of ATP may be similarly directed toward the repair of DNA and diverted away from the ATP-dependent steps required for the execution phase of apoptosis. In particular, the formation of the apoptosome [44], [45], [46], [47], [48], [49], the multimeric complex consisting of dATP, Apaf-1 and cytochrome c necessary for the formation of active caspase-9 [50], and the activation of downstream effector caspases (e.g. caspase-3, -6 and -7) during the demolition phase of apoptosis [46], [49], [51], require dATP or ATP [36], [37]. In addition, in the face of excessive DNA damage, ATP is diverted from maintaining the ion pumps (Fig. 2). In the case of the Ca++-ATPase, energy depletion prevents Ca++ ions from being extruded from the cell, thereby increasing the intracellular Ca++ concentration from nanomolar to lethal micromolar concentrations. The influx of excessive Ca++ activates calcium-dependent phospholipases, nucleases and proteases, which dramatically injure the cell. Failure of the Na+, K+-ATPase causes excessive amounts of Na+ to enter the cell, followed by a large influx of water, resulting in cellular swelling and lysis. Since K+ normally prevents apoptosis [52] by inhibiting the Apaf-1 oligomerization step in the formation of the apoptosome [53], the efflux of K+ from the cell will help shift the mode of cell death from apoptosis to necrosis. It may be that, in order to ensure that apoptosis occurs instead of necrosis in the face of excessive DNA damage, key proteins involved in DNA repair that are consumers of energy are cleaved and inactivated during apoptosis, such as ATM [54], [55], DNA-PK [56], hsRad51 [57], [58], [59] and PARP [60], [61], [62], [63]. Inactivation of these proteins diverts ATP from DNA repair, and may also prevent confusing pro-survival signals. In addition to the formation of the apoptosome, ATP is also necessary for the accumulation and stabilization of p53 [27], a DNA damage-responsive transcription factor that increases the expression of pro-apoptotic proteins [64] (e.g. bax) which damage the mitochondrial outer membrane with the release of cytochrome c (Fig. 2) [65]. p53 also increases the expression of Apaf-1 [66], [67], which is part of the apoptosome. During DNA damage-induced apoptosis, p53 has also been reported to directly target the mitochondria [47].
The cleavage of PARP during apoptosis appears to be an especially critical step, since PARP rapidly consumes NAD+, the pyridine nucleotide, which, in its reduced form, contributes electrons to complex I of the mitochondrial electron transport chain (Fig. 2). The NAD+ precursors, nicotinic acid and nicotinamide, in fact, can protect against apoptosis induced by the multiple stress-inducer, deoxycholate [68]. Since PARP also poly(ADP) ribosylates and inhibits p53 [69], PARP cleavage will result in the activation of p53 (Fig. 2). The cleavage of PARP also results in a gain-of-function, which augments the loss of PARP activity [70]. After cleavage by caspase-3, the N-terminal apoptotic fragment of PARP retains a strong DNA binding activity and totally inhibits the catalytic activity of uncleaved PARP [70]. Fig. 2 outlines a mechanism whereby the cell senses the presence of too much DNA damage, and shunts the available ATP toward apoptosis, while at the same time, maintaining ion pumps that prevent cellular lysis. In vivo, cell fate will culminate with the phagocytosis of the apoptotic cell and/or apoptotic bodies. In vitro, cell fate will culminate in the eventual loss of ion pumps, a fate termed “secondary necrosis” of apoptotic cells. Since phagocytes are usually absent from most in vitro culture systems, phagocytosis of early apoptotic cells does not occur.
Over time, a high level of apoptosis can lead to clonal selection of apoptosis-resistant cells. The generation of mutations as a consequence of increased unrepaired DNA damage in apoptosis-resistant, proliferating cells appears to be an important aspect of the development of cancer at numerous sites within the body. This is exemplified by the natural progression of follicular lymphoma to high-grade lymphoma [71]. The constitutive presence of bcl-2 confers apoptosis resistance on follicular lymphoma cells, which then allows mutations and chromosomal aberrations to increase. As reviewed next, the mechanism of apoptosis resistance involves, in part, the loss of key bi-functional proteins which are necessary for initiation of both apoptosis and DNA repair. Loss of apoptosis competence coupled with loss of capability to repair DNA damage increases genomic instability which in turn accelerates progression to cancer (Fig. 1) [72].
Five major DNA repair pathways are homologous recombinational repair (HRR); non-homologous end joining (NHEJ); nucleotide excision repair (NER); base excision repair (BER); and mismatch repair (MMR) [73]. We review evidence that key proteins associated with these five major forms of DNA repair also have a role in triggering cell cycle arrest and apoptosis (Table 1).
Section snippets
Homologous recombinational repair (HRR)
In HRR, sequence information that is lost due to damage in one double-stranded DNA molecule is accurately replaced by physical exchange of a segment from an homologous intact DNA molecule. We focus on seven genes directly involved in HRR that are also involved in apoptosis (Table 1, Fig. 3). These are breast cancer-associated gene 1 (BRCA1), ATM, ATM-related (ATR), Werner syndrome gene (WRN), Bloom syndrome gene (BLM), Tip60 and p53. We also discuss Rad51 and BRCA2 because of their role in the
Non-homologous end-joining (NHEJ)
There are two distinct mechanisms for repairing double-strand breaks, HRR and NHEJ. HRR is thought to be largely accurate by analogy with this process in microorganisms. NHEJ is regarded as largely inaccurate because it involves end-joining reactions with junctions containing deletions back to regions of microhomology of 1–10 bases within 20 base pairs of the ends [154]. Mammalian cells repair the majority of double-strand breaks by NHEJ [154], although there is evidence that NHEJ may be
Nucleotide excision repair (NER)
NER repairs DNA with helix-distorting damages, including the damages of cyclobutane pyrimidine dimers and 6–4 photoproducts produced by UV light, and adducts produced by the chemotherapeutic agents cisplatin and 4-nitroquinoline oxide [166], [168]. About 30 polypeptides are involved in NER, and the NER process has been reconstituted with purified components (summarized in [167]). Key steps of NER (see Fig. 5 for some of these steps) include: (i) recognition of a DNA defect; (ii) recruitment of
Base excision repair (BER)
BER is a major DNA repair pathway protecting mammalian cells against single-base DNA damage caused by methylating and oxidizing agents, other genotoxicants, and a large number (about 10,000 per cell per day) of spontaneous depurinations [197]. BER is mediated through at least two subpathways, one involving single nucleotide BER and the other involving longer patch BER of 2–15 nucleotides. BER can be initiated through removal of a damaged base by a DNA glycosylase, which binds the altered
Mismatch repair (MMR)
A highly conserved set of MMR proteins in humans is primarily responsible for the post-replication correction of nucleotide mispairs and extra-helical loops. Mutational defects in MMR genes in humans give rise to a mutator phenotype, microsatellite instability, and a predisposition to cancer. MMR mutations are implicated in the etiology of hereditary non-polyposis colorectal cancer (HNPCC) syndrome [221] and a wide variety of sporadic tumors. The MMR system is also involved in the cellular
Activation of p53 through increased stability
p53, in unstressed cells, is present in a latent state and is maintained at low levels by targeted degradation. Different genotoxic stresses, including double-strand breaks produced by IR and lesions resulting from UV irradiation or chemical damage to DNA, initiate signaling pathways that transiently stabilize p53, causing it to accumulate in the nucleus and activate it as a transcription factor [230]. After DNA damage, the level of p53 increases largely because the half-life of the protein is
Induction of apoptosis by DNA damage: role of Bcl-2 family proteins
The Bcl-2 family of cell death regulators plays a crucial role in determining cell fate in the apoptotic pathway. The anti-apoptotic members of the Bcl-2 family include Bcl-xL, Bfl-1 and Mcl-1, and the pro-apoptotic members include Bax, Bcl-xS, Nbk, Bak, Bad and Bid. Both Bcl-2 and Bax are associated with the outer membrane of mitochondria, the endoplasmic reticulum and the nuclear envelope [247]. Bax forms channels in lipid membranes and the pro-apoptotic effect of Bax appears to be elicited
Reduction of apoptosis capability during progression to cancer
We now discuss evidence indicating that defects in the recognition of excess damage and/or failure of the apoptotic machinery to act on this information leads to genomic instability and progression to cancer.
The switch from repair to apoptosis
A key unresolved issue is how a cell “determines” when DNA damage is “excessive” and how this determination triggers the shift from repair to apoptosis. It seems plausible that proteins employed in recognition of DNA damage in order to initiate repair may also use this recognition capability to help trigger cell cycle arrest followed by apoptosis when damage is excessive. Altogether, about 130 genes have been identified in the human genome whose products are employed in DNA repair [73]. As
Acknowledgments
Supported by grants NIH Program Project Grant CA72008, Arizona Disease Control Research Commission Grants 10016 and 6002, NIH Institutional Core Grant CA23074, NIEHS Grant ES06694, NIH Grants CA43894 and CA65579, and VAH Merit Review Grant 2HG.
References (291)
- et al.
Mutations in apoptosis genes: a pathogenetic factor for human disease
Mutat. Res.
(2001) p53, the cellular gatekeeper for growth and division
Cell
(1997)- et al.
Molecular failure of apoptosis: inappropriate cell survival and mutagenesis
Toxicol. Lett.
(1998) - et al.
The shape of cell death
Biochem. Biophys. Res. Commun.
(1997) - et al.
Alterations in deoxynucleoside triphosphate metabolism in DNA damaged cells: identification and consequences of poly(ADP-ribose) polymerase dependent and independent processes
Biochem. Biophys. Res. Commun.
(1986) - et al.
Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion
Biochem. Biophys. Res. Commun.
(1994) - et al.
RecA protein: structure, function, and role in recombinational DNA repair
Prog. Nucl. Acid Res. Mol. Biol.
(1997) - et al.
ATP-dependent assembly of a ternary complex consisting of a DNA mismatch and the yeast MSH2–MSH6 and MLH1–PMS1 protein complexes
J. Biol. Chem.
(1998) - et al.
The RAD51 family member, RAD51L3, is a DNA-stimulated ATPase that forms a complex with XRCC2
J. Biol. Chem.
(2000) - et al.
Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily
Cell
(2000)
ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose)
J. Biol. Chem.
Distinct MutS DNA-binding modes that are differentially modulated by ATP binding and hydrolysis
J. Biol. Chem.
ATM phosphorylates histone H2AX in response to DNA double-strand breaks
J. Biol. Chem.
Direct observation of three conformations of MutS protein regulated by adenine nucleotides
J. Mol. Biol.
Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c
Cell
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
Cell
A primary role for K+ and Na+ efflux in the activation of apoptosis
J. Biol. Chem.
The apoptosome: heart and soul of the cell death machine
Neoplasia
An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
J. Biol. Chem.
Mitochondria as the central control point of apoptosis
Trends Cell Biol.
Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling
J. Biol. Chem.
The mitochondrial apoptosome: a killer unleashed by the cytochrome seas
Trends Biochem. Sci.
Programmed cell death: alive and well in the new millennium
Trends Cell Biol.
Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
Mol. Cell
Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis
J. Biol. Chem.
Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome
J. Biol. Chem.
Proteolytic cleavage of HsRad51 during apoptosis
FEBS Lett.
Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis
Exp. Cell Res.
Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines
Toxicol. Appl. Pharmacol.
Bh3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability
J. Biol. Chem.
Bcl-2 initiates a new category of oncogenes: regulators of cell death
Blood
BRCA1 controls homology-directed DNA repair
Mol. Cell
Repression of BRCA1 through a feedback loop involving p53
J. Biol. Chem.
Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
Cell
BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer lines
J. Biol. Chem.
Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer
Cancer Genet. Cytogenet.
Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
Mol. Cell
Insights into the functions of BRCA1 and BRCA2
TIG
Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis
Ultrastruct. Pathol.
Reduced bile acid-induced apoptosis in normal colorectal mucosa: a potential biological marker for cancer risk
Cancer Res.
A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies
Cancer Res.
Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus
Arch. Surg.
Apoptotic and proliferative activity in the neoplastic progression of Barrett’s oesophagus: a comparative study
J. Pathol.
Inhibition of Bax channel-forming activity by Bcl-2
Science
Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis
Oncogene
Suppression of apoptosis by Bcl-2 to enhance benzene metabolites-induced oxidative DNA damage and mutagenesis: a possible mechanism of carcinogenesis
Mol. Pharmacol.
Genetic instabilities in human cancers
Nature
Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance
Pathol. Annu.
Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways
Leuk. Lymphoma
Cited by (472)
DARVIC: Dihedral angle-reliant variant impact classifier for functional prediction of missense VUS
2023, Computer Methods and Programs in BiomedicineSex steroid hormones and DNA repair regulation: Implications on cancer treatment responses
2023, Journal of Steroid Biochemistry and Molecular BiologyTrans-resveratrol imparts disparate effects on transcription of DNA damage sensing/repair pathway genes in euglycemic and hyperglycemic rat testis
2021, Toxicology and Applied Pharmacology
- 1
Present address: Arizona Cancer Center, Tucson, AZ 85724, USA.